Sophia Genetics Sa (SOPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -73,356 | -49,941 | -25,254 | -73,507 | -51,608 |
| Depreciation Amortization | 4,020 | 2,575 | 1,188 | 3,609 | 2,380 |
| Accounts receivable | -693 | -791 | -2 | 1,806 | -1,168 |
| Accounts payable and accrued liabilities | 963 | 3,543 | 2,140 | 8,980 | 8,111 |
| Other Working Capital | -1,285 | 2,942 | 3,351 | 6,065 | 188 |
| Other Operating Activity | 10,587 | 4,727 | 1,178 | -4,892 | -423 |
| Operating Cash Flow | $-59,764 | $-36,945 | $-17,399 | $-57,939 | $-42,520 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 63,505 | 42,337 | 21,646 | 21,878 | 10,968 |
| PPE Investments | -2,176 | -1,266 | -561 | -2,683 | -2,532 |
| Purchase Of Investment | -26,462 | -10,585 | -10,824 | -72,141 | -61,421 |
| Purchase Sale Intangibles | -1,497 | -1,009 | -334 | -130 | -132 |
| Other Investing Activity | -5,032 | -3,783 | -1,547 | -3,988 | -2,662 |
| Investing Cash Flow | $29,835 | $26,703 | $8,714 | $-56,934 | $-55,647 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -3,167 | -3,167 |
| Common Stock Issued | 748 | 759 | 59 | 216,190 | 216,434 |
| Other Financing Activity | -1,736 | -938 | -470 | 24,750 | 24,953 |
| Financing Cash Flow | $-988 | $-179 | $-411 | $237,773 | $238,220 |
| Exchange Rate Effect | -4,218 | -3,640 | -953 | -4,563 | -4,688 |
| Beginning Cash Position | 192,962 | 192,962 | 192,962 | 74,625 | 74,625 |
| End Cash Position | 157,827 | 178,901 | 182,913 | 192,962 | 209,990 |
| Net Cash Flow | $-35,135 | $-14,061 | $-10,049 | $118,337 | $135,365 |
| Free Cash Flow | |||||
| Operating Cash Flow | -59,764 | -36,945 | -17,399 | -57,939 | -42,520 |
| Capital Expenditure | -2,176 | -1,266 | -561 | -2,683 | -2,532 |
| Free Cash Flow | -61,940 | -38,211 | -17,960 | -60,622 | -45,052 |